Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.

org/wiki/Deep_vein_thrombosis

From Wikipedia, the free encyclopedia

In medicine, deep vein thrombosis (also known as deep venous thrombosis and usually Deep vein thrombosis
abbreviated as DVT) is the formation of a blood clot ("thrombus") in a deep vein. It is a form of
Classification and external resources
thrombophlebitis (inflammation of a vein with clot formation).

Deep vein thrombosis commonly affects the leg veins (such as the femoral vein or the popliteal
vein) or the deep veins of the pelvis. Occasionally the veins of the arm are affected (if
spontaneous, this is known as Paget-Schrötter disease). A DVT can occur without symptoms, but in
many cases the affected extremity will be painful, swollen, red, warm and the superficial veins may
be engorged. The most serious complication of a DVT is that the clot could dislodge and travel to
the lungs, which is called a pulmonary embolism (PE). DVT is a medical emergency, so, all limb
swellings, however trivial, should be regarded as a DVT until proven otherwise. Untreated lower
extremity DVT has a 3% PE-related mortality rate. Deaths associated with upper extremity DVT
are extremely rare.[1] A late complication of DVT is the post-thrombotic syndrome, which can
manifest itself as edema, pain or discomfort and skin problems.

According to Virchow's triad, venous thrombosis occurs via three mechanisms: decreased flow rate
of the blood, damage to the blood vessel wall and an increased tendency of the blood to clot
(hypercoagulability). Several medical conditions can lead to DVT, such as compression of the
veins, physical trauma, cancer, infections, certain inflammatory diseases and specific conditions
such as stroke, heart failure or nephrotic syndrome. There are several factors which can increase a
person's risk for DVT, including surgery, hospitalization, immobilization (such as when orthopedic
casts are used, or during long-haul flights, leading to traveller's thrombosis), smoking, obesity, age,
certain drugs (such as estrogen, or erythropoietin) and inborn tendencies to form clots known as A deep vein thrombosis of the right leg. Note the
thrombophilia (for example, in carriers of factor V Leiden). Women have an increased risk during swelling and redness.
pregnancy, if they are on the Pill, and in the postnatal period, due to increased estrogen levels.
ICD-10 I80.2 (http://apps.who.int
The most commonly used tests for the diagnosis of DVT are a blood test called D-dimers and /classifications/apps/icd/icd10online
doppler ultrasound of the affected veins. Sometimes, further testing is required to find the cause of /?gi80.htm+i802)
the DVT. In specific cases, an attempt can be made to break down the clot (using thrombolytic
agents). To prevent further accrual and formation of new clots with a risk of pulmonary embolism, ICD-9 453.40 (http://www.icd9data.com
anticoagulation (blood thinners) is advised (if not possible, an inferior vena cava filter may be /getICD9Code.ashx?icd9=453.40)
used). Prevention of DVT is advised in many medical and surgical inpatients using anticoagulants, DiseasesDB 3498
graduated compression stockings (also known as thromboembolic deterrent stockings) or
intermittent pneumatic compression (IPC) devices.

1 of 13 24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Deep_vein_thrombosis

(http://www.diseasesdatabase.com
/ddb3498.htm)

MedlinePlus 000156 (http://www.nlm.nih.gov

1 Signs and symptoms
/medlineplus/ency/article
2 Cause
3 Diagnosis /000156.htm)
3.1 Physical examination eMedicine med/2785
3.2 Probability scoring (http://www.emedicine.com
3.3 Blood tests
/med/topic2785.htm)
3.4 Imaging
MeSH D020246 (http://www.nlm.nih.gov
4 Prevention
4.1 General medical inpatients /cgi/mesh/2011/MB_cgi?field=uid&
4.2 Surgery patients term=D020246)
4.3 Pregnancy
4.4 Travellers
5 Management
5.1 Anticoagulation
5.2 Thrombolysis
5.3 Thrombectomy
5.4 Compression stockings
5.5 Inferior vena cava filter
5.6 Hospitalization
6 Prognosis
7 Epidemiology
8 See also
9 References
10 External links

There may be no symptoms referable to the location of the DVT, but the classical symptoms of DVT include pain, swelling and redness of the leg and
dilation of the surface veins. In up to 25% of all hospitalized patients, there may be some form of DVT, which often remains clinically inapparent
(unless pulmonary embolism develops).

2 of 13 24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Deep_vein_thrombosis

There are several techniques during physical examination to increase the detection of DVT, such as measuring the circumference of the affected and
the contralateral limb at a fixed point (to objectivate edema), and palpating the venous tract, which is often tender. Physical examination is unreliable
for excluding the diagnosis of deep vein thrombosis.

In phlegmasia alba dolens, the leg is pale and cool with a diminished arterial pulse caused by spasm. It usually results from acute occlusion of the iliac
and femoral veins because of DVT.

In phlegmasia cerulea dolens, there is an acute and nearly total venous occlusion of the entire extremity outflow, including the iliac and femoral veins.
The leg is usually painful, cyanosed (blue from lack of oxygen) and edematous (filled with fluid). Venous gangrene may supervene.

It is vital that the possibility of pulmonary embolism be included in the history, as this may warrant further investigation (see pulmonary embolism).

A careful history has to be taken considering risk factors (see below), including the use of estrogen-containing methods of hormonal contraception,
recent long-haul flying, intravenous drug use and a history of miscarriage (which is a feature of several disorders that can also cause thrombosis). In
the case of long-haul flying, recent studies have shown that risk of DVT is higher in travellers who smoke, are obese, or are currently taking
contraceptive pills.[2] A family history can reveal a hereditary factor in the development of DVT. Approximately 35 percent of DVT patients have at
least one hereditary thrombophilia, including deficiencies in the anticoagulation factors protein C, protein S, antithrombin, or mutations in the factor V
and prothrombin genes.[3]

Main article: Thrombosis

Virchow's triad is a group of three factors known to affect clot formation: rate of flow, the consistency (thickness) of the blood, and qualities of the
vessel wall. Virchow noted that more deep venous thrombosis occurred in the left leg than in the right and proposed compression of the left common
iliac vein by the overlying right common iliac artery as the underlying cause (see May-Thurner syndrome).[4]

The most common risk factors are recent surgery or hospitalization.[5][6] 40% of these patients did not receive heparin prophylaxis. Other risk factors
include advanced age, obesity, infection, immobilization, use of combined (estrogen-containing) forms of hormonal contraception, tobacco usage and
air travel ("economy class syndrome", a combination of immobility and relative dehydration).[6][7] Thrombophilia (tendency to develop thrombosis)
often expresses itself with recurrent thromboses.

It is recognized that thrombi usually develop first in the calf veins, "growing" in the direction of flow of the vein. DVTs are distinguished as being
above or below the popliteal vein. Very extensive DVTs can extend into the iliac veins or the inferior vena cava. The risk of pulmonary embolism is
higher in the presence of more extensive clots.

3 of 13 24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Deep_vein_thrombosis

The gold standard is intravenous venography, which involves injecting a peripheral vein of the affected limb
with a contrast agent and taking X-rays, to reveal whether the venous supply has been obstructed. Because of
its invasiveness, this test is rarely performed.

Physical examination

Homans sign: Dorsiflexion of foot elicits pain in posterior calf. Pratt's sign: Squeezing of posterior calf elicits
pain. However, these medical signs do not perform well and are not included in clinical prediction rules that
combine best findings in order to diagnose DVT.[8]
Abdominal computed tomographic
Probability scoring
scan showing a common iliac vein
thrombosis. The arrow indicates the
In 2006, Scarvelis and Wells overviewed a set of clinical prediction rules for DVT,[9] on the heels of a widely
filling defect in the vein visualised
adopted set of clinical criteria for pulmonary embolism.[10][11] using radiocontrast.

Wells score or criteria: (Possible score -2 to 9)

1. Active cancer (treatment within last 6 months or palliative) +1 point

2. Calf swelling >3 cm compared to other calf (measured 10 cm below tibial tuberosity) +1 point
3. Collateral superficial veins (non-varicose) +1 point
4. Pitting edema (confined to symptomatic leg) +1 point
5. Previous documented DVT +1 point.
6. Swelling of entire leg +1 point
7. Localized pain along distribution of deep venous system +1 point
8. Paralysis, paresis, or recent cast immobilization of lower extremities +1 point
9. Recently bedridden > 3 days, or major surgery requiring regional or general anesthetic in past 4 weeks +1 point
10. Alternative diagnosis at least as likely -2 points

Interpretation:

Score of 2 or higher - deep vein thrombosis is likely. Consider imaging the leg veins.
Score of less than 2 - deep vein thrombosis is unlikely. Consider blood test such as d-dimer test to further rule out deep vein thrombosis.

Blood tests

4 of 13 24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Deep_vein_thrombosis

D-dimer

Main article: d-dimer

In a low-probability situation, current practice is to commence investigations by testing for D-dimer levels. This cross-linked fibrin degradation
product is an indication that thrombosis is occurring, and that the blood clot is being dissolved by plasmin. A low D-dimer level should prompt other
possible diagnoses (such as a ruptured Baker's cyst, if the patient is at sufficiently low clinical probability of DVT).[12][13]

Other blood tests

Other blood tests usually performed at this point are[citation needed]:

complete blood count

Primary coagulation studies: PT, APTT, Fibrinogen
liver enzymes
renal function and electrolytes

Imaging

Impedance plethysmography, Doppler ultrasonography, compression ultrasound scanning of the leg veins,
combined with duplex measurements (to determine blood flow), can reveal a blood clot and its extent (i.e.
whether it is below or above the knee). Duplex Ultrasonography, due to its high sensitivity, specificity and
reproducibility, has replaced venography as the most widely used test in the evaluation of the disease. This test
involves both a B mode image and Doppler flow analysis. It is most sensitive and specific for detecting
proximal thrombi (in the popliteal and femoral veins), but substantially less so for distal thrombi (in the calf
veins).[14]

Clinical practice guidelines by the American College of Chest Physicians (ACCP) provide recommendations
on DVT prophylaxis in hospitalized patients.[15]
An ultrasound image demonstrating a
General medical inpatients blood clot in the left common femoral
vein.
Regarding general medical inpatients the guidelines state, "In acutely ill medical patients who have been
admitted to the hospital with congestive heart failure or severe respiratory disease, or who are confined to bed

5 of 13 24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Deep_vein_thrombosis

and have one or more additional risk factors, including active cancer, previous VTE, sepsis, acute neurologic disease, or inflammatory bowel disease,
we recommend prophylaxis with low-dose unfractionated heparin-LDUH (Grade 1A) or LMWH (Grade 1A).[15]" Enoxaparin or unfractionated
heparin may be used.[16] LMWH may be more effective than unfractionated heparin (UFH). If UFH is used, 5000 U 3 times daily may be more
effective.[17]

Since publication of the ACCP guidelines, an additional randomized controlled trial[18] and meta-analysis[19] including the trial have been published.
The meta-analysis concluded " Anticoagulant prophylaxis is effective in preventing symptomatic venous thromboembolism during anticoagulant
prophylaxis in at-risk hospitalized medical patients. Additional research is needed to determine the risk for venous thromboembolism in these patients
after prophylaxis has been stopped." With regards to which patients are at risk, most studies in the meta-analysis were of patients with New York
Heart Association Functional Classification (NYHA) III-IV heart failure. Regarding patients at lesser risk of DVT, the trial above[18] and an earlier
trial[20] are relevant yet inconclusive.

Since the ACCP guidelines, compression stockings have been studied for preventing clots in stroke patients.[21][22] In stroke patients, thigh-length
stockings are more effective than knee stockings in the nonblinded CLOTS 2 randomized controlled trial[22] while thigh-length stockings were not
better than no stockings in the CLOTS 1 nonblinded randomized controlled trial.[21] It is not clear why these two trials conflict.[23]

Chronic renal dialysis patients may be at increased risk of thromboembolism,[24] but randomized controlled trials have not addressed the risk benefit
of prophylaxis.

Surgery patients

In patients who have undergone surgery, low molecular weight heparins (LMWH) are routinely administered to prevent thrombosis. LMWH can only
currently be administered subcutaneously by injection. Prophylaxis for pregnant women who have a history of thrombosis may be limited to LMWH
injections or may not be necessary if their risk factors are mainly temporary.

Early and regular ambulation (walking) is a treatment that predates anticoagulants and is still recognized and used today. Walking activates the body's
muscle pumps, increasing venous velocity and preventing stasis. IPC devices have proven protective in bed- or chair-ridden patients at very high risk
or with contraindications to heparins. IPC machines use air bladders that are wrapped around the thigh and/or calf. The bladders alternately inflate
and deflate, squeezing the muscles and increasing blood velocity by as much as 500%. IPC machines have been proven effective on knee and hip
surgery patients (a population with a risk as high as 80% with no prophylactic treatment) of developing DVT and PE.

Pregnancy
Main article: Hypercoagulability in pregnancy

The risk of deep vein thrombosis is increased in pregnancy because of a physiologically adaptive mechanism of increased hypercoagulability to

6 of 13 24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Deep_vein_thrombosis

prevent postpartum hemorrhage.[25] However, when combined with an additional underlying hypercoagulable states, the risk of thrombosis or
embolism may become substantial.[25]

While the general consensus among physicians is that the safety of the mother supersedes the safety of the developing fetus, changes in the
anticoagulation regimen during pregnancy can be performed to minimize the risks to the developing fetus while maintaining therapeutic levels of
anticoagulation in the mother.

The main issue with anticoagulation in pregnancy is that warfarin, the most commonly used anticoagulant in chronic administration, is known to have
teratogenic effects on the fetus if administered in early pregnancy.[26][27]

Travellers
Main article: Traveller's thrombosis

There is clinical evidence to suggest that wearing compression socks or compression tights while travelling also reduces the incidence of thrombosis in
people on long haul flights. A randomised study in 2001 compared two sets of long haul airline passengers, one set wore travel compression hosiery
the others did not. The passengers were all scanned and blood tested to check for the incidence of DVT. The results showed that asymptomatic DVT
occurred in 10% of the passengers who did not wear compression tights. The group wearing compression hosiery had no DVTs. The authors
concluded that wearing elastic compression hosiery reduces the incidence of DVT in long haul airline passengers.[28]

Anticoagulation
Main article: Anticoagulation

Anticoagulation is the usual treatment for DVT. In general, patients are initiated on a brief course (i.e., less than a week) of heparin treatment while
they start on a 3- to 6-month course of warfarin (or related vitamin K inhibitors). Low molecular weight heparin (LMWH) is preferred,[29] though
unfractionated heparin is given in patients who have a contraindication to LMWH (e.g., renal failure or imminent need for invasive procedure). In
patients who have had recurrent DVTs (two or more), anticoagulation is generally "life-long." The Cochrane Collaboration has meta-analyzed the risk
and benefits of prolonged anti-coagulation.[30] Once the thrombosis is treated with RBC-thinning agents, the affected area has a fair chance of
returning to its normal proportions. However, thinning agents do not lessen the chance of embolism to the pulmonary or coronary arteries. Thus, while
the area affected with deep venous thrombosis (i.e. the legs) may cease coagulation, pulmonary embolism is still as possible. In a 2008 Cochrane
review, it was found that anticoagulation used in combination with leg compression is a more effective therapy than anticoagulation alone.[31]

An abnormal D-dimer level at the end of treatment might signal the need for continued treatment among patients with a first unprovoked proximal

7 of 13 24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Deep_vein_thrombosis

deep-vein thrombosis.[32]

Despite the fact that no one disputes this, based on a meta analysis done by the Cochrane Collaboration where they found only one randomized trial
of anti coagulation vs placebo in the treatment of VTE in which there was no significant difference between the two.[33]

Current recommendations for initial treatment of acute DVT include initiation of a vitamin K antagonist (VKA) together with LMWH or UFH on the
first treatment day.[34] Heparin may be discontinued when the international normalized ratio (INR) is stable and greater than 2.0. For the duration and
intensity of treatment for acute DVT of the leg, the recommendations include the following:

for patients with a first episode of DVT secondary to a transient (reversible) risk factor, long-term treatment with a VKA for 3 months.
for patients with a first episode of idiopathic DVT, treatment with a VKA for at least 6 to 12 months. The dose of VKA is adjusted to maintain
INR in the range of 2.0 to 3.0.
for the prevention of the post-thrombotic syndrome, the use of an elastic compression stocking is recommended.

Thrombolysis
Main article: Thrombolysis

Thrombolysis is generally reserved for extensive clot, e.g. an iliofemoral thrombosis. Although a meta-analysis of randomized controlled trials by the
Cochrane Collaboration shows improved outcomes with thrombolysis,[35] there may be an increase in serious bleeding complications. In July 2008,
the American College of Chest Physicians (ACCP) published new evidence-based clinical guidelines for the treatment of venous thromboembolic
(VTE) disease which for the first time suggested the use of pharmacomechanical thrombolysis in the treatment of certain cases of acute DVT.
Complete 2008 ACCP VTE guidelines can be downloaded at no charge at: TheNewGuidelines.org (http://www.TheNewGuidelines.org)

Thrombectomy

Thrombus can be removed with a mechanical thrombectomy device. Combination therapy that uses mechanical thrombectomy to deliver localized
thrombolytics has recently received considerable attention as a treatment for DVT.

Compression stockings

Elastic compression stockings should be routinely applied "beginning within 1 month of diagnosis of proximal DVT and continuing for a minimum of
1 year after diagnosis".[29] Starting within one week may be more effective.[36] They reduce the risk of postthrombotic syndrome.[37] The stockings
in almost all trials were stronger than routine anti-embolism stockings and created either 20–30 mm Hg or 30–40 mm Hg. Most trials used knee-high
stockings. A meta-analysis of randomized controlled trials by the Cochrane Collaboration showed reduced incidence of post-thrombotic
syndrome.[38] The number needed to treat is relatively high, at 4 to 5 patients needing to have been treated to prevent one case of post-thrombotic

8 of 13 24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Deep_vein_thrombosis

syndrome.[39]

Inferior vena cava filter

Main article: Inferior vena cava filter

Inferior vena cava filter reduces pulmonary embolism[40] and is an option for patients with an absolute contraindiciation to anticoagulant treatment
(e.g., cerebral hemorrhage) or those rare patients who have objectively documented recurrent PEs while on anticoagulation, an inferior vena cava
filter (also referred to as a Greenfield filter) may prevent pulmonary embolisation of the leg clot. However these filters are themselves potential of
thrombosis,[41] IVC filters are viewed as a temporizing measure for preventing life-threatening pulmonary embolism.[42]

Hospitalization

Treatment at home is an option according to a meta-analysis by the Cochrane Collaboration.[43] Hospitalization should be considered in patients with
more than two of the following risk factors as these patients may have more risk of complications during treatment[44]:

bilateral DVT
renal insufficiency
low body weight (<70 kg/154 lbs)
recent immobility
chronic heart failure
cancer

Post-thrombotic syndrome occurs in 15% of patients with deep vein thrombosis (DVT). It presents with leg edema, pain, nocturnal cramping, venous
claudication, skin pigmentation, dermatitis and ulceration (usually on the medial aspect of the lower leg).

DVTs occur in about 1 per 1000 persons per year. It is estimated that approximately 350,000 to 600,000 Americans each year suffer from DVT and
pulmonary embolism and at least 100,000 deaths may be directly or indirectly related to these diseases.[45]

DVT is much less common in the pediatric population. About 1 in 100,000 people under the age of 18 experiences deep vein thrombosis, possibly due
to a child's high rate of heartbeats per minute, relatively active lifestyle when compared with adults, and fewer comorbidities (e.g. malignancy).

9 of 13 24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia
In pregnant women, it has an incidence of 0.5 to 7 per 1,000 pregnancies, and is the second most common cause of maternal death in developed
countries after bleeding.[46]
Venogram (medical)
1. ^ by Alexander G.G. Turpie, MD (last modified March 2008). "Deep
Venous Thrombosis - The Merck's Manuals Online Medical Library"
(http://www.merck.com/mmpe/sec07/ch081/ch081b.html?qt=dvt&
alt=sh#sec07-ch081-ch081b-1775) . http://www.merck.com/mmpe/sec07
/ch081/ch081b.html?qt=dvt&alt=sh#sec07-ch081-ch081b-1775.
2. ^ Firkin, F and Nandurkar, H(2009). "Flying and thromboembolism".
Australian Prescriber, 32:148-50. Available at
http://www.australianprescriber.com/magazine/32/6/148/50/
3. ^ Rosendall FR. (2005). "Venous Thrombosis: the role of genes,
environment, and behavior.". Hematology Am Soc Hematol Educ
Program 2005: 1–12. doi:10.1182/asheducation-2005.1.1
(http://dx.doi.org/10.1182%2Fasheducation-2005.1.1) . PMID 16304352
(http://www.ncbi.nlm.nih.gov/pubmed/16304352) .
4. ^ Virchow R. Ueber die Erweiterung kleinerer Gefäfse. Arch Pathol Anat
Physiol Klin Med 1851;3:427-62.
5. ^ Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ (2007).
"Venous thromboembolism in the outpatient setting"
(http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&
artid=2762787) . Arch. Intern. Med. 167 (14): 1471–5.
doi:10.1001/archinte.167.14.1471 (http://dx.doi.org
/10.1001%2Farchinte.167.14.1471) . PMC 2762787
(http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&
artid=2762787) . PMID 17646600 (http://www.ncbi.nlm.nih.gov/pubmed
/17646600) . http://www.pubmedcentral.nih.gov
/articlerender.fcgi?tool=pmcentrez&artid=2762787.
6. ^ a b Bulger CM, Jacobs C, Patel NH Epidemiology of acute deep vein
thrombosis.Tech Vasc Interv Radiol. 2004 Jun;7(2):50-4. PMID:
15252760
7. ^ Tsai A, Cushman M, Rosamond W, Heckbert S, Polak J, Folsom A
(2002). "Cardiovascular risk factors and venous thromboembolism
10 of 13
http://en.wikipedia.org/wiki/Deep_vein_thrombosis
incidence: the longitudinal investigation of thromboembolism etiology".
Arch Intern Med 162 (10): 1182–9. doi:10.1001/archinte.162.10.1182
(http://dx.doi.org/10.1001%2Farchinte.162.10.1182) . PMID 12020191
(http://www.ncbi.nlm.nih.gov/pubmed/12020191) .
8. ^ Wells PS, Owen C, Doucette S, Fergusson D, Tran H (2006). "Does
this patient have deep vein thrombosis?". JAMA 295 (2): 199–207.
doi:10.1001/jama.295.2.199 (http://dx.doi.org
/10.1001%2Fjama.295.2.199) . PMID 16403932
(http://www.ncbi.nlm.nih.gov/pubmed/16403932) .
9. ^ Scarvelis D, Wells P (2006). "Diagnosis and treatment of deep-vein
thrombosis" (http://www.pubmedcentral.nih.gov
/articlerender.fcgi?tool=pmcentrez&artid=1609160) . CMAJ 175 (9):
1087–92. doi:10.1503/cmaj.060366 (http://dx.doi.org
/10.1503%2Fcmaj.060366) . PMC 1609160
(http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&
artid=1609160) . PMID 17060659 (http://www.ncbi.nlm.nih.gov/pubmed
/17060659) . http://www.pubmedcentral.nih.gov
/articlerender.fcgi?tool=pmcentrez&artid=1609160.
10. ^ Neff MJ. ACEP releases clinical policy on evaluation and management
of pulmonary embolism. American Family Physician. 2003; 68(4):759-?.
Available at: http://www.aafp.org/afp/20030815/practice.html. Accessed
on: December 8, 2006.
11. ^ Wells P, Anderson D, Rodger M, Ginsberg J, Kearon C, Gent M, Turpie
A, Bormanis J, Weitz J, Chamberlain M, Bowie D, Barnes D, Hirsh J
(2000). "Derivation of a simple clinical model to categorize patients
probability of pulmonary embolism: increasing the models utility with the
SimpliRED D-dimer". Thromb Haemost 83 (3): 416–20.
PMID 10744147 (http://www.ncbi.nlm.nih.gov/pubmed/10744147) .
12. ^ Wells PS, Anderson DR, Rodger M, et al. (2003). "Evaluation of
D-dimer in the diagnosis of suspected deep-vein thrombosis". N. Engl. J.
24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia
Med. 349 (13): 1227–35. doi:10.1056/NEJMoa023153 (http://dx.doi.org
/10.1056%2FNEJMoa023153) . PMID 14507948
(http://www.ncbi.nlm.nih.gov/pubmed/14507948) .
13. ^ Bates SM, Kearon C, Crowther M, et al. (2003). "A diagnostic strategy
involving a quantitative latex D-dimer assay reliably excludes deep
venous thrombosis". Ann. Intern. Med. 138 (10): 787–94.
PMID 12755550 (http://www.ncbi.nlm.nih.gov/pubmed/12755550) .
14. ^ Elizabeth D Agabegi; Agabegi, Steven S. (2008). Step-Up to Medicine
(Step-Up Series). Hagerstwon, MD: Lippincott Williams & Wilkins.
ISBN 0-7817-7153-6.
15. ^ a b Geerts WH, Pineo GF, Heit JA, et al. (September 2004).
"Prevention of venous thromboembolism: the Seventh ACCP Conference
on Antithrombotic and Thrombolytic Therapy". Chest 126 (3 Suppl):
338S–400S. doi:10.1378/chest.126.3_suppl.338S (http://dx.doi.org
/10.1378%2Fchest.126.3_suppl.338S) . PMID 15383478
(http://www.ncbi.nlm.nih.gov/pubmed/15383478) .
16. ^ King CS, Holley AB, Jackson JL, Shorr AF, Moores LK (2007). "Twice
vs three times daily heparin dosing for thromboembolism prophylaxis in
the general medical population: A metaanalysis". Chest 131 (2): 507–16.
doi:10.1378/chest.06-1861 (http://dx.doi.org/10.1378%2Fchest.06-1861)
. PMID 17296655 (http://www.ncbi.nlm.nih.gov/pubmed/17296655) .
17. ^ Wein L, Wein S, Haas SJ, Shaw J, Krum H (2007). "Pharmacological
Venous Thromboembolism Prophylaxis in Hospitalized Medical Patients:
A Meta-analysis of Randomized Controlled Trials". Archives of Internal
Medicine 167 (14): 1476–1486. doi:10.1001/archinte.167.14.1476
(http://dx.doi.org/10.1001%2Farchinte.167.14.1476) . PMID 17646601
(http://www.ncbi.nlm.nih.gov/pubmed/17646601) .
18. ^ a b Lederle FA, Sacks JM, Fiore L, et al. (January 2006). "The
prophylaxis of medical patients for thromboembolism pilot study". Am. J.
Med. 119 (1): 54–9. doi:10.1016/j.amjmed.2005.03.049 (http://dx.doi.org
/10.1016%2Fj.amjmed.2005.03.049) . PMID 16431185
(http://www.ncbi.nlm.nih.gov/pubmed/16431185) .
19. ^ Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA (February
2007). "Meta-analysis: anticoagulant prophylaxis to prevent symptomatic
venous thromboembolism in hospitalized medical patients"
(http://annals.org/cgi/content/full/146/4/278) . Ann. Intern. Med. 146 (4):
278–88. PMID 17310052 (http://www.ncbi.nlm.nih.gov/pubmed
/17310052) . http://annals.org/cgi/content/full/146/4/278.
20. ^ Gärdlund B; Gårdlund, B. (May 1996). "Randomised, controlled trial of
low-dose heparin for prevention of fatal pulmonary embolism in patients
with infectious diseases. The Heparin Prophylaxis Study Group". Lancet
11 of 13
http://en.wikipedia.org/wiki/Deep_vein_thrombosis
347 (9012): 1357–61. doi:10.1016/S0140-6736(96)91009-0
(http://dx.doi.org/10.1016%2FS0140-6736%2896%2991009-0) .
PMID 8637340 (http://www.ncbi.nlm.nih.gov/pubmed/8637340) .
21. ^ a b "Effectiveness of thigh-length graduated compression stockings to
reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a
multicentre, randomised controlled trial". The Lancet 373: 1958–1965.
2009. doi:10.1016/S0140-6736(09)60941-7 (http://dx.doi.org
/10.1016%2FS0140-6736%2809%2960941-7) .
22. ^ a b The CLOTS (Clots in Legs Or sTockings after Stroke) Trial
Collaboration (2010). "Thigh-Length Versus Below-Knee Stockings for
Deep Venous Thrombosis Prophylaxis After Stroke: A Randomized
Trial". Annals of internal medicine 153 (9): 553–562.
doi:10.1059/0003-4819-153-9-201011020-00280 (http://dx.doi.org
/10.1059%2F0003-4819-153-9-201011020-00280) . PMID 20855784
(http://www.ncbi.nlm.nih.gov/pubmed/20855784) .
23. ^ 20855785
24. ^ Tveit DP, Hypolite IO, Hshieh P, et al. (2002). "Chronic dialysis
patients have high risk for pulmonary embolism". Am. J. Kidney Dis. 39
(5): 1011–7. doi:10.1053/ajkd.2002.32774 (http://dx.doi.org
/10.1053%2Fajkd.2002.32774) . PMID 11979344
(http://www.ncbi.nlm.nih.gov/pubmed/11979344) .
25. ^ a b Page 264 in: Gresele, Paolo (2008). Platelets in hematologic and
cardiovascular disorders: a clinical handbook. Cambridge, UK:
Cambridge University Press. ISBN 0-521-88115-3.
26. ^ Sathienkijkanchai A, Wasant P. (2005). "Fetal warfarin syndrome". J
Med Assoc Thai 88 (Suppl 8): S246–50. PMID 16856447
(http://www.ncbi.nlm.nih.gov/pubmed/16856447) .
27. ^ Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T,
Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M,
Rodriguez-Pinilla E, Dolivo A, Merlob P. (2006). "Vitamin K antagonists
and pregnancy outcome. A multi-centre prospective study". Thromb
Haemost 95 (6): 949–57. doi:10.1160/TH06-02-0108 (http://dx.doi.org
/10.1160%2FTH06-02-0108) . PMID 16732373
(http://www.ncbi.nlm.nih.gov/pubmed/16732373) .
28. ^ Scurr JH, Machin SJ, Bailey-King S, Mackie IJ, McDonald S, Smith PD
(May 2001). "Frequency and prevention of symptomless deep-vein
thrombosis in long-haul flights: a randomised trial". Lancet 357 (9267):
1485–9. doi:10.1016/S0140-6736(00)04645-6 (http://dx.doi.org
/10.1016%2FS0140-6736%2800%2904645-6) . PMID 11377600
(http://www.ncbi.nlm.nih.gov/pubmed/11377600) .
29. ^ a b Snow V, Qaseem A, Barry P, et al. (2007). "Management of venous
24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia
thromboembolism: a clinical practice guideline from the American
College of Physicians and the American Academy of Family Physicians"
(http://www.annals.org/cgi/content/full/146/3/204) . Ann. Intern. Med. 146
(3): 204–10. PMID 17261857 (http://www.ncbi.nlm.nih.gov/pubmed
/17261857) . http://www.annals.org/cgi/content/full/146/3/204.
30. ^ Hutten BA, Prins MH (2006). Prins, Martin H. ed. "Duration of
treatment with vitamin K antagonists in symptomatic venous
thromboembolism". Cochrane database of systematic reviews (Online)
(1): CD001367. doi:10.1002/14651858.CD001367.pub2
(http://dx.doi.org/10.1002%2F14651858.CD001367.pub2) .
PMID 16437432 (http://www.ncbi.nlm.nih.gov/pubmed/16437432) .
31. ^ Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP,
Reddy DJ. Combined intermittent pneumatic leg compression and
pharmacological prophylaxis for prevention of venous thromboembolism
in high-risk patients. Cochrane Database of Systematic Reviews 2008,
Issue 4. Art. No.: CD005258. DOI: 10.1002/14651858.CD005258.pub2
http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD005258
/frame.html
32. ^ Palareti G, Cosmi B, Legnani C, et al. (2006). "D-dimer testing to
determine the duration of anticoagulation therapy". N. Engl. J. Med. 355
(17): 1780–9. doi:10.1056/NEJMoa054444 (http://dx.doi.org
/10.1056%2FNEJMoa054444) . PMID 17065639
(http://www.ncbi.nlm.nih.gov/pubmed/17065639) .
33. ^ Cundiff DK, Manyemba J, Pezzullo JC (2006). Cundiff, David K. ed.
"Anticoagulants versus non-steroidal anti-inflammatories or placebo for
treatment of venous thromboembolism". Cochrane Database Syst Rev
(1): CD003746. doi:10.1002/14651858.CD003746.pub2
(http://dx.doi.org/10.1002%2F14651858.CD003746.pub2) .
PMID 16437461 (http://www.ncbi.nlm.nih.gov/pubmed/16437461) .
34. ^ Harry R. Büller, Giancarlo Agnelli, Russel D. Hull, Thomas M. Hyers,
Martin H. Prins, and Gary E. Raskob (September 2004). "Antithrombotic
Therapy for Venous Thromboembolic Disease: The Seventh ACCP
Conference on Antithrombotic and Thrombolytic Therapy"
(http://chestjournal.chestpubs.org/content/126/3_suppl/401S.full) . Chest
126 (3): 401S–428S. doi:10.1378/chest.126.3_suppl.401S
(http://dx.doi.org/10.1378%2Fchest.126.3_suppl.401S) . PMID 15383479
(http://www.ncbi.nlm.nih.gov/pubmed/15383479) .
http://chestjournal.chestpubs.org/content/126/3_suppl/401S.full.
Retrieved 12 August 2010.
35. ^ Watson L, Armon M (2004). Watson, Lorna. ed. "Thrombolysis for
acute deep vein thrombosis". Cochrane Database Syst Rev (4):
12 of 13
http://en.wikipedia.org/wiki/Deep_vein_thrombosis
CD002783. doi:10.1002/14651858.CD002783.pub2 (http://dx.doi.org
/10.1002%2F14651858.CD002783.pub2) . PMID 15495034
(http://www.ncbi.nlm.nih.gov/pubmed/15495034) .
36. ^ Prandoni P, Lensing AW, Prins MH, et al. (2004). "Below-knee elastic
compression stockings to prevent the post-thrombotic syndrome: a
randomized, controlled trial". Ann. Intern. Med. 141 (4): 249–56.
PMID 15313740 (http://www.ncbi.nlm.nih.gov/pubmed/15313740) .
37. ^ Musani MH, Matta F, Yaekoub AY, Liang J, Hull RD, Stein PD (August
2010). "Venous compression for prevention of postthrombotic syndrome:
a meta-analysis". Am. J. Med. 123 (8): 735–40.
doi:10.1016/j.amjmed.2010.01.027 (http://dx.doi.org
/10.1016%2Fj.amjmed.2010.01.027) . PMID 20670728
(http://www.ncbi.nlm.nih.gov/pubmed/20670728) .
38. ^ Kolbach D, Sandbrink M, Hamulyak K, Neumann H, Prins M (2003).
Kolbach, Dinanda N. ed. "Non-pharmaceutical measures for prevention
of post-thrombotic syndrome". Cochrane Database Syst Rev (1):
CD004174. doi:10.1002/14651858.CD004174.pub2 (http://dx.doi.org
/10.1002%2F14651858.CD004174.pub2) . PMID 14974060
(http://www.ncbi.nlm.nih.gov/pubmed/14974060) .
39. ^ Kakkos S, Daskalopoulou S, Daskalopoulos M, Nicolaides A,
Geroulakos G (2006). "Review on the value of graduated elastic
compression stockings after deep vein thrombosis". Thromb Haemost 96
(4): 441–5. PMID 17003920 (http://www.ncbi.nlm.nih.gov/pubmed
/17003920) .
40. ^ Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P,
Laporte S, Faivre R, Charbonnier B, Barral F, Huet Y, Simonneau G
(1998). "A clinical trial of vena caval filters in the prevention of
pulmonary embolism in patients with proximal deep-vein thrombosis.
Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study
Group". N Engl J Med 338 (7): 409–15.
doi:10.1056/NEJM199802123380701 (http://dx.doi.org
/10.1056%2FNEJM199802123380701) . PMID 9459643
(http://www.ncbi.nlm.nih.gov/pubmed/9459643) .
41. ^ Prepic Study, Group (2005). "Eight-year follow-up of patients with
permanent vena cava filters in the prevention of pulmonary embolism: the
PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption
Cave) randomized study". Circulation 112 (3): 416–22.
doi:10.1161/CIRCULATIONAHA.104.512834 (http://dx.doi.org
/10.1161%2FCIRCULATIONAHA.104.512834) . PMID 16009794
(http://www.ncbi.nlm.nih.gov/pubmed/16009794) .
42. ^ Young T, Aukes J, Hughes R, Tang H (2007). Young, Tim. ed. "Vena
24-May-11 6:34 AM
Deep vein thrombosis - Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Deep_vein_thrombosis

caval filters for the prevention of pulmonary embolism". Cochrane
database of systematic reviews (Online) (3): CD006212.
doi:10.1002/14651858.CD006212.pub2 (http://dx.doi.org
/10.1002%2F14651858.CD006212.pub2) . PMID 17636834
(http://www.ncbi.nlm.nih.gov/pubmed/17636834) .
43. ^ Othieno R, Abu Affan M, Okpo E (2007). Othieno, Richard. ed. "Home
versus in-patient treatment for deep vein thrombosis". Cochrane
database of systematic reviews (Online) (3): CD003076.
doi:10.1002/14651858.CD003076.pub2 (http://dx.doi.org
/10.1002%2F14651858.CD003076.pub2) . PMID 17636714
(http://www.ncbi.nlm.nih.gov/pubmed/17636714) .
44. ^ Trujillo-Santos J, Herrera S, Page MA, et al. (2006). "Predicting
adverse outcome in outpatients with acute deep vein thrombosis. findings
from the RIETE Registry". J. Vasc. Surg. 44 (4): 789–93.
doi:10.1016/j.jvs.2006.06.032 (http://dx.doi.org
/10.1016%2Fj.jvs.2006.06.032) . PMID 16926081
(http://www.ncbi.nlm.nih.gov/pubmed/16926081) .
45. ^ "The Surgeon General's Call to Action to Prevent Deep Vein
Thrombosis and Pulmonary Embolism 2008"
(http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-
to-action-on-dvt-2008.pdf) (PDF). http://www.surgeongeneral.gov/topics
/deepvein/calltoaction/call-to-action-on-dvt-2008.pdf. Retrieved
2008-10-13.
46. ^ Venös tromboembolism (VTE) - Guidelines for treatment in C counties.
Bengt Wahlström, Emergency department, Uppsala Academic Hospital.
January 2008

North American Thrombosis Forum: Patients and Health Professionals working together to enhance prevention, diagnosis and treatment of
thrombosis and cardiovascular diseases. (http://www.NATFonline.org)
American College of Chest Physicians 2008 Clinical Evidence-based Guidelines for Venous Thromboembolic Disease (VTE)
(http://chestjournal.chestpubs.org/content/133/6_suppl)
International Society on Thrombosis and Haemostasis (http://www.isth.org/)
Ongoing campaign to change Scottish doctors and hospitals procedures regarding DVT (http://www.dvt-awareness.co.uk/)
DVT patient information (http://www.debakeydepartmentofsurgery.org/home/content.cfm?proc_name=Deep+Vein+Thrombosis&
content_id=272)
A Lighter Vein.com - DVT Prevention & Compression Hosiery (http://www.alightervein.com)
Retrieved from "http://en.wikipedia.org/wiki/Deep_vein_thrombosis"
Categories: Hematology | Angiology | Vascular surgery | Diseases of veins, lymphatic vessels and lymph nodes

This page was last modified on 20 May 2011 at 09:35.

Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. See Terms of Use for details.
Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.

13 of 13 24-May-11 6:34 AM